Alexander Lozano Samaniego
Alexander Lozano Samaniego has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Amada Barcia Cansino
Sociedad Ecuatoriana de Reumatología, Guayaquil, Ecuador
1 shared publication - Andrés Eduardo Zúñiga Vera
Hospital Universitario de la Plana, Valencia, España
1 shared publication - Carlos Eduardo Encalada García
Sociedad Ecuatoriana de Reumatología, Guayaquil, Ecuador
1 shared publication - Cesar Marcelo Delgado Viteri
Centro de Especialidades Respiratorias
1 shared publication - Enrique Jaramillo
Hospital de especialidades Alfredo Paulson, Guayaquil, Ecuador
1 shared publication - Fabián Matías Caro
Hospital de Rehabilitación Respiratoria María Ferrer, Buenos Aires, Argentina
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (4) , 492-503
Consenso multidisciplinario de cribado y diagnóstico de enfermedad pulmonar intersticial (EPI) asociada a enfermedades reumáticas autoinmunes sistémicas (ERAS)
Introduction: Interstitial lung disease (ILD) is a common and high-impact manifestation in patients with systemic autoimmune rheumatic diseases (SARDs). Timely detection requires clinical tools based on evidence and multidisciplinary consensus. Methods: A multidisciplinary team developed the consensus for the screening and diagnosis of ILD-SARDs through the formulation of PICO clinical questions, a systematic literature review (2017–2023) reported in accordance with the PRISMA statement, evaluation of the evidence using the GRADE system, and the formulation of clinical practice recommendations, which were validated using the Delphi methodology. Results: Twelve key recommendations were established for the screening and diagnosis of interstitial lung disease (ILD) in patients with Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE), Sjögren’s Syndrome (SS), Mixed Connective Tissue Disease (MCTD) and Idiopathic Inflammatory Myopathies (IIM). The use of high-resolution computed tomography (HRCT) and pulmonary function tests is highlighted as fundamental diagnostic tools. Respiratory assessment is recommended at each visit, along with active surveillance of fibrotic progression risk in diagnosed patients. Routine lung biopsy is not suggested, except in cases of suspected malignancy or discordant diagnoses. Conclusion: The implementation of evidence-based recommendations for the screening and diagnosis of ILD-SARDs aims to improve early detection, multidisciplinary intervention and patient prognosis. Their adoption can help standardize clinical practices and optimize care across all levels of the healthcare system.
- 1 December 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (4) , 492-503
Open AccessConsenso multidisciplinario de cribado y diagnóstico de enfermedad pulmonar intersticial (EPI) asociada a enfermedades reumáticas autoinmunes sistémicas (ERAS)
Introduction: Interstitial lung disease (ILD) is a common and high-impact manifestation in patients with systemic autoimmune rheumatic diseases (SARDs). Timely detection requires clinical tools based on evidence and multidisciplinary consensus. Methods: A multidisciplinary team developed the consensus for the screening and diagnosis of ILD-SARDs through the formulation of PICO clinical questions, a systematic literature review (2017–2023) reported in accordance with the PRISMA statement, evaluation of the evidence using the GRADE system, and the formulation of clinical practice recommendations, which were validated using the Delphi methodology. Results: Twelve key recommendations were established for the screening and diagnosis of interstitial lung disease (ILD) in patients with Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc), Systemic Lupus Erythematosus (SLE), Sjögren’s Syndrome (SS), Mixed Connective Tissue Disease (MCTD) and Idiopathic Inflammatory Myopathies (IIM). The use of high-resolution computed tomography (HRCT) and pulmonary function tests is highlighted as fundamental diagnostic tools. Respiratory assessment is recommended at each visit, along with active surveillance of fibrotic progression risk in diagnosed patients. Routine lung biopsy is not suggested, except in cases of suspected malignancy or discordant diagnoses. Conclusion: The implementation of evidence-based recommendations for the screening and diagnosis of ILD-SARDs aims to improve early detection, multidisciplinary intervention and patient prognosis. Their adoption can help standardize clinical practices and optimize care across all levels of the healthcare system.
- Open Access
- 8 January 2024
- Published by MedCrave Group Kft. in MOJ Surgery
- Vol. 12 (1) , 1-4
Decoding complex mediastinal masses in children: insights from a clinical case
Introduction: In the pediatric population, any mediastinal mass represents a diagnostic challenge considering that most of these lesions have been associated with neoplasms. Advanced imaging modalities such as computed tomography (CT) have proven essential for the identification and characterization of mediastinal lesions. Objective: To explore the general nature of nerve cell tumors with a radiological approach. Clinical case: Three-year-old girl with respiratory symptoms with a mass in the mesogastrium of approximately 3 cm. Abdominal ultrasound reports a complex mass. Chest X-ray evidenced radiopacity in the left hemithorax. Plain contrast-enhanced CT of the chest and upper abdomen shows a solid, contrast-enhancing mass with a volume of approximately 387 cc. Discussion: In the posterior mediastinum, nerve cell tumors are generally grouped into three categories: peripheral nerve, paraganglia, or autonomic ganglion cells, whether sympathetic or parasympathetic, with an incidence of 70%, 25%, and 1-2%. respectively. Conclusion: Posterior mediastinal lesions in pediatric patients should focus on the study of lymph node tumors due to their high incidence, in addition, they should be evaluated using objective radiological characteristics to avoid complications and consequently take prompt therapeutic action.
- 8 January 2024
- Published by MedCrave Group Kft. in MOJ Surgery
- Vol. 12 (1) , 1-4
Open AccessDecoding complex mediastinal masses in children: insights from a clinical case
Introduction: In the pediatric population, any mediastinal mass represents a diagnostic challenge considering that most of these lesions have been associated with neoplasms. Advanced imaging modalities such as computed tomography (CT) have proven essential for the identification and characterization of mediastinal lesions. Objective: To explore the general nature of nerve cell tumors with a radiological approach. Clinical case: Three-year-old girl with respiratory symptoms with a mass in the mesogastrium of approximately 3 cm. Abdominal ultrasound reports a complex mass. Chest X-ray evidenced radiopacity in the left hemithorax. Plain contrast-enhanced CT of the chest and upper abdomen shows a solid, contrast-enhancing mass with a volume of approximately 387 cc. Discussion: In the posterior mediastinum, nerve cell tumors are generally grouped into three categories: peripheral nerve, paraganglia, or autonomic ganglion cells, whether sympathetic or parasympathetic, with an incidence of 70%, 25%, and 1-2%. respectively. Conclusion: Posterior mediastinal lesions in pediatric patients should focus on the study of lymph node tumors due to their high incidence, in addition, they should be evaluated using objective radiological characteristics to avoid complications and consequently take prompt therapeutic action.